Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 29 (PRR29) is a human protein encoded by the PRR29 gene located on chromosome 17q23.3. It is characterized by a stretch of five proline amino acids and contains a DUF4587 domain. Although the exact function remains unclear, it is suggested to be involved in communication between the cell nucleus and mitochondria, potentially affecting cellular signaling and energy production. Additionally, PRR29 may act as a structural component necessary for assembly or maintenance of the ciliary axoneme; its proline-rich composition could facilitate critical protein-protein interactions. PRR29 is expressed in multiple tissues, notably in the circulatory and immune systems, but there is no experimental evidence that it serves as an enzyme, transporter, receptor, or other classical therapeutic target. Currently, no drugs, biomarkers, or clinical disease associations are established for PRR29[1][3][4][5][6][9].
None identified
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 29 (PRR29).